Loading…

MoS2@Ti3C2 nanohybrid-based photoelectrochemical biosensor: A platform for ultrasensitive detection of cancer biomarker exosomal miRNA

As a class of newly identified biomarkers, miRNAs show enormous potential in cancer diagnosis. The sensitive detection of abnormal miRNAs concentration to realize early diagnosis of malignant tumors is a frontier in the field of biosensing. In this work, a photoelectrochemical (PEC) biosensor based...

Full description

Saved in:
Bibliographic Details
Published in:Talanta (Oxford) 2022-02, Vol.238, p.123077-123077, Article 123077
Main Authors: Sun, Zhiwei, Tong, Yao, Zhao, Li, Li, Juan, Gao, Fucheng, Wang, Chuanxin, Li, Hui, Du, Lutao, Jiang, Yanyan
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:As a class of newly identified biomarkers, miRNAs show enormous potential in cancer diagnosis. The sensitive detection of abnormal miRNAs concentration to realize early diagnosis of malignant tumors is a frontier in the field of biosensing. In this work, a photoelectrochemical (PEC) biosensor based on MoS2@Ti3C2 nanohybrid was fabricated for the ultrasensitive detection of miRNAs. The hybridization of Ti3C2 with excellent electron transfer capability significantly enhances the photocurrent response of the PEC biosensor. Moreover, the electrodeposition of Au nanoparticles on the surface of MoS2@Ti3C2 nanohybrid further enhances the photocurrent. The detection performance of the PEC biosensor has been tested using colorectal cancer-related exosomal miRNA (miR-92a-3p) as the target. The PEC biosensor shows a broad linear detection ranged from 1 fM to 100 nM and a calculated detection limit of 0.27 fM. In terms of selectivity, the PEC biosensor can distinguish miR-92a-3p from mismatched sequences. The 16 continuous radiation source on-off cycles test indicates the high stability of the PEC biosensor. Furthermore, the accurate detection of exosomal miR-92a-3p concentrations of patients and healthy controls demonstrates the clinical feasibility of the PEC biosensor. Based on these outcomes, the PEC biosensor exhibits the prospect of realizing the ultrasensitive point-of-care detection of miRNAs. [Display omitted] •A MoS2@Ti3C2 nanohybrid-based PEC platform was fabricated for biosensing.•Ti3C2 enhances the photocurrent response of MoS2 through rapid electron transfer.•The PEC biosensor can accurately detect the concentration of exosomal miRNA.
ISSN:0039-9140
1873-3573
DOI:10.1016/j.talanta.2021.123077